Biodexa Pharmaceuticals Plc (BDRX)

1.32 -0.19 (-12.58%) USD  |  NASDAQ  |  May 01, 16:00
1.31 -0.01 (-0.76%) After-Hours: 05:37
More

Biodexa Pharmaceuticals Shareholders Equity (Quarterly): 5.959M for Dec. 31, 2023

Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2014. Upgrade now.
Date Value
December 31, 2023 5.959M
June 30, 2023 6.684M
June 30, 2023 6.684M
December 31, 2022 3.827M
June 30, 2022 9.086M
June 30, 2022 9.086M
December 31, 2021 14.11M
June 30, 2021 5.193M
June 30, 2021 5.193M
December 31, 2020 9.156M
June 30, 2020 5.597M
June 30, 2020 5.597M
December 31, 2019 25.64M
June 30, 2019 31.37M
Date Value
June 30, 2019 31.37M
December 31, 2018 21.47M
June 30, 2018 30.56M
June 30, 2018 30.56M
December 31, 2017 46.86M
June 30, 2017 47.90M
June 30, 2017 47.90M
December 31, 2016 56.17M
June 30, 2016 54.83M
June 30, 2016 54.83M
December 31, 2015 69.46M
June 30, 2015 58.38M
June 30, 2015 58.38M
December 31, 2014 65.35M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

3.827M
Minimum
Dec 2022
31.37M
Maximum
Jun 2019
11.64M
Average
6.684M
Median
Jun 2023

Shareholders Equity (Quarterly) Benchmarks

Adaptimmune Therapeutics PLC 39.51M
NuCana PLC 18.96M
Autolus Therapeutics PLC 111.47M
Mereo BioPharma Group PLC 50.54M
Bicycle Therapeutics PLC 370.93M

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly) 13.43M
Total Liabilities (Quarterly) 7.470M
Current Ratio 1.262